Yuan Huagang 袁华刚

袁华刚先生,汉族,中国国籍,无境外永久居留权,1973年出生,浙江大学经济学学士和澳门大学MBA,通过国内律师资格和保荐代表人资格考试,长期从事并购重组及各项创新业务。袁华刚先生曾任国泰君安证券股份有限公司投资银行部执行董事、董事总经理、副总经理职务、保荐代表人,浙江民营企业联合投资股份有限公司管理合伙人,派斯双林生物制药股份有限公司(SZ.000403)董事、总经理。目前担任惠州市亿纬锂能股份有限公司(SZ.300014)高级副总裁,北京福田亿纬新能源科技有限公司董事,上海新华传媒股份有限公司(SH.600625)独立董事,杭州泰格医药科技股份有限公司(SZ.300347)独立董事。于2024年10月28日起任公司独立董事。

English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Mr. Yuan Huagang, Han ethnicity, Chinese nationality, no overseas permanent residence, born in 1973, 浙江大学经济学学士和澳门大学 MBA, passed the domestic lawyer qualification and sponsor representative qualification exams, has long been engaged in mergers and acquisitions, restructuring, and various innovation businesses. Mr. Yuan Huagang has served as Executive Director, Managing Director, Deputy General Manager, and sponsor representative of the Investment Banking Department of 国泰君安证券股份有限公司, a managing partner of 浙江民营企业联合投资股份有限公司, and a director and general manager of 派斯双林生物制药股份有限公司 (Pacific Shuanglin Bio-pharmacy) (SZ.000403). Currently serves as Senior Vice President of 惠州市亿纬锂能股份有限公司 (SZ.300014), a director of 北京福田亿纬新能源科技有限公司, an independent director of 上海新华传媒股份有限公司 (Xinhua Media) (SH.600625), and an independent director of 杭州泰格医药科技股份有限公司 (Hangzhou Tigermed Consulting) (SZ.300347). Appointed as the company's independent director effective October 28, 2024.